TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ELVN

Enliven Therapeutics Inc.

Healthcare · Biotechnology

45.20$ -2.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ELVN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2.03 -2.03 -5.06 -1.94 -2.45 -5.13 -1.72 -1.55 -1.24
– – 0.01 0.01 0.01 0.03 0.01 0.01 0.00
– 0.13 0.21 0.03 0.25 0.51 0.36 0.43 0.60
– – – 2.23 0.25 – – – –
-0.04 0.29 0.16 0.13 0.46 0.07 0.04 -0.10 -0.02
0.00 0.00 0.03 0.10 0.02 0.10 0.00 0.00 0.00
– – -5.57 -0.10 -0.02 -0.10 -4.18 -0.76 -3.07
– – – – -0.03 0.00 – – 0.01
2.55 1.50 10.09 29.73 -0.13 -0.29 6.59 2.83 3.86
0.51 -0.53 -0.57 27.68 -2.60 -5.52 0.69 0.51 -0.45
-2.03 -2.03 -5.10 -2.05 -2.47 -5.23 -1.73 -1.56 -1.24

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?